Sangamo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.About SGMO
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases.
CEOAlexander D. Macrae
CEOAlexander D. Macrae
Employees183
Employees183
HeadquartersRichmond, California
HeadquartersRichmond, California
Founded1995
Founded1995
Employees183
Employees183
SGMO Key Statistics
Market cap157.51M
Market cap157.51M
Price-Earnings ratio-1.80
Price-Earnings ratio-1.80
Dividend yield—
Dividend yield—
Average volume4.34M
Average volume4.34M
High today—
High today—
Low today—
Low today—
Open price$0.5134
Open price$0.5134
Volume101.00
Volume101.00
52 Week high$3.18
52 Week high$3.18
52 Week low$0.4111
52 Week low$0.4111
SGMO News
Seeking Alpha 6d
Sangamo Therapeutics falls on CFO retirementHealthcare Sangamo Therapeutics falls on CFO retirement Sep. 12, 2025 9:03 AM ET Sangamo Therapeutics, Inc. (SGMO) Stock By: Nilanjana Basu, SA News Editor 5 Sh...
TipRanks 7d
Sangamo Biosciences CFO Resignation AnnouncedElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
33.3%
Sell
0%
People also own
Based on the portfolios of people who own SGMO. This list is generated using Robinhood data, and it’s not a recommendation.